Trastuzumab deruxtecan (anti-ERBB2) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan (anti-ERBB2) is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd). Trastuzumab deruxtecan (anti-ERBB2) can be used for the research of HER2-positive breast cancer and gastric cancer.
Specification: ExactAb™, Recombinant, Validated, Azide Free, Low Endotoxin, Carrier Free, ≥90%(SDS-PAGE&SEC)
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB183313-SCI_e93a31bdb002480150500377d54407e0.pdf
- UPC:
- 51202411
- Condition:
- New
- Availability:
- 5-10 days
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab183313-100μg
- CAS:
- 1826843-81-5
- Product Size:
- 100μg